SLCO1B1 (1865+4846T>C) was identified in a genome-wide association study as one of the most important factors influencing MTX clearance in patients with acute lymphoblastic leukemia (ALL) (12). Here, SLCO1B1 is linked to acute lymphoblastic leukemia.